Wir verwenden Cookies und Analyse-Tools, um die Nutzerfreundlichkeit der Internet-Seite zu verbessern und für Marketingzwecke. Wenn Sie fortfahren, diese Seite zu verwenden, nehmen wir an, dass Sie damit einverstanden sind. Zur Datenschutzerklärung.
Antigens from Leishmania Amastigotes, protect Human against Leishmania
Details
In the endemic "Valle Arriba" neighborhood, located in Caracas, Venezuela, with leishmaniasis morbidity 24.76 o/oo, an amastigotes vaccine with four Leishmania species was applied for protection against leishmaniasis in 3,191 people with a follow up of three years and also in hyperendemic "El Ingenio" with morbidity of 164.04 o/oo. The vaccine contains 8-10 proteins after treatment amastigotes with TLCK and NP40. Before the vaccine both vaccinated and control groups had 24% of positive volunteers to Delayed Type Hypersensitivity intradermic reaction with vaccine antigens. One month after three vaccines, 95.67% of vaccinees previously DTH negative converted to a positive DTH. The morbidity rate was 7.94 o/oo in the vaccinated group, and 56.17 in the control-unvaccinated group, an incidence 7.07 times bigger after three years of the field trial. In "La Planta" hyperendemic zone 41.78% were DTH positive before vaccination, with 122 cases from 1972-1994 and highest morbidity (205.23 o/oo) in 0-5 years old, which points out to intra-domiciliary transmission of the disease . ELISA and immunoblottings were equal before and after vaccination, the vaccine induced cellular immunity.
Autorentext
Jose Antonio O'Daly Carbonell. Amerikanischer Staatsbürger. Geburtsland: Caracas, Venezuela. Sekundarschule: La-Salle-Gymnasium Caracas. Universität: Zentraluniversität von Venezuela Caracas: MD 1958-1964 DMSc 1965-1968. Johns Hopkins Universität PhD 1967-1071. Veröffentlichungen Internationale Fachzeitschriften mit Peer-Review 117 Eingeladen von den Herausgebern 18. Insgesamt 135.
Klappentext
In the endemic "Valle Arriba" neighborhood, located in Caracas, Venezuela, with leishmaniasis morbidity 24.76 o/oo, an amastigotes vaccine with four Leishmania species was applied for protection against leishmaniasis in 3,191 people with a follow up of three years and also in hyperendemic "El Ingenio" with morbidity of 164.04 o/oo. The vaccine contains 8-10 proteins after treatment amastigotes with TLCK and NP40. Before the vaccine both vaccinated and control groups had 24% of positive volunteers to Delayed Type Hypersensitivity intradermic reaction with vaccine antigens. One month after three vaccines, 95.67% of vaccinees previously DTH negative converted to a positive DTH. The morbidity rate was 7.94 o/oo in the vaccinated group, and 56.17 in the control-unvaccinated group, an incidence 7.07 times bigger after three years of the field trial. In "La Planta" hyperendemic zone 41.78% were DTH positive before vaccination, with 122 cases from 1972-1994 and highest morbidity (205.23 o/oo) in 0-5 years old, which points out to intra-domiciliary transmission of the disease . ELISA and immunoblottings were equal before and after vaccination, the vaccine induced cellular immunity.
Weitere Informationen
- Allgemeine Informationen
- GTIN 09783330083110
- Sprache Englisch
- Größe H220mm x B150mm
- Jahr 2017
- EAN 9783330083110
- Format Kartonierter Einband
- ISBN 978-3-330-08311-0
- Veröffentlichung 30.05.2017
- Titel Antigens from Leishmania Amastigotes, protect Human against Leishmania
- Autor Jose O'Daly
- Herausgeber LAP LAMBERT Academic Publishing
- Anzahl Seiten 104
- Genre Medical Books